1. Home
  2. BOLD vs MOBX Comparison

BOLD vs MOBX Comparison

Compare BOLD & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • MOBX
  • Stock Information
  • Founded
  • BOLD 2018
  • MOBX 2020
  • Country
  • BOLD United States
  • MOBX United States
  • Employees
  • BOLD N/A
  • MOBX N/A
  • Industry
  • BOLD
  • MOBX
  • Sector
  • BOLD
  • MOBX
  • Exchange
  • BOLD Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • BOLD 30.3M
  • MOBX 29.6M
  • IPO Year
  • BOLD 2024
  • MOBX N/A
  • Fundamental
  • Price
  • BOLD $1.50
  • MOBX $0.72
  • Analyst Decision
  • BOLD Hold
  • MOBX
  • Analyst Count
  • BOLD 1
  • MOBX 0
  • Target Price
  • BOLD N/A
  • MOBX N/A
  • AVG Volume (30 Days)
  • BOLD 63.1K
  • MOBX 108.6K
  • Earning Date
  • BOLD 05-16-2025
  • MOBX 05-20-2025
  • Dividend Yield
  • BOLD N/A
  • MOBX N/A
  • EPS Growth
  • BOLD N/A
  • MOBX N/A
  • EPS
  • BOLD N/A
  • MOBX N/A
  • Revenue
  • BOLD N/A
  • MOBX $9,326,000.00
  • Revenue This Year
  • BOLD N/A
  • MOBX N/A
  • Revenue Next Year
  • BOLD N/A
  • MOBX N/A
  • P/E Ratio
  • BOLD N/A
  • MOBX N/A
  • Revenue Growth
  • BOLD N/A
  • MOBX 1023.61
  • 52 Week Low
  • BOLD $1.06
  • MOBX $0.55
  • 52 Week High
  • BOLD $12.26
  • MOBX $3.44
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • MOBX 40.96
  • Support Level
  • BOLD N/A
  • MOBX $0.67
  • Resistance Level
  • BOLD N/A
  • MOBX $0.75
  • Average True Range (ATR)
  • BOLD 0.00
  • MOBX 0.06
  • MACD
  • BOLD 0.00
  • MOBX 0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • MOBX 41.83

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: